mRNA |
pifithrin-alpha |
CTRPv2 |
pan-cancer |
AAC |
0.038 |
0.3 |
mRNA |
selumetinib:MK-2206 (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.036 |
0.3 |
mRNA |
elocalcitol |
CTRPv2 |
pan-cancer |
AAC |
0.035 |
0.3 |
mRNA |
palmostatin B |
CTRPv2 |
pan-cancer |
AAC |
-0.045 |
0.3 |
mRNA |
selumetinib:piperlongumine (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.035 |
0.3 |
mRNA |
BRD-A02303741:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.036 |
0.3 |
mRNA |
YL54 |
CTRPv2 |
pan-cancer |
AAC |
-0.039 |
0.3 |
mRNA |
Bortezomib |
CTRPv2 |
pan-cancer |
AAC |
0.034 |
0.3 |
mRNA |
canertinib |
CTRPv2 |
pan-cancer |
AAC |
0.036 |
0.3 |
mRNA |
itraconazole |
CTRPv2 |
pan-cancer |
AAC |
0.038 |
0.3 |